Showing results (1-10 of 61) with videos related to
Sort By:
Pageof 7
Investigative Ophthalmology & Visual Science|December 10, 1999
Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal spaceH Wenkel, P W Chen, B R Ksander, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 1, 1997
Expression of MAGE genes in ocular melanoma cell linesP W Chen, T G Murray, M L Salgaller, et al.Investigative Ophthalmology & Visual Science|December 31, 1997
Gene transfer of the CD80 costimulatory molecule into ocular melanoma cells using a novel episomal vectorT Uno, P W Chen, T G Murray, et al.Clinical & Experimental Metastasis|September 1, 1997
Expression of MAGE genes in ocular melanoma during progression from primary to metastatic diseaseP W Chen, T G Murray, T Uno, et al.Current Eye Research|April 2, 1998
Uveal melanomas contain antigenically specific and non-specific infiltrating lymphocytesB R Ksander, D C Geer, P W Chen, et al.Transplantation|April 1, 1989
Immune privilege to MHC-disparate tumor grafts in the anterior chamber of the eye. I. Quantitative analysis of intraocular tumor growth and the corresponding delayed hypersensitivity responseB R Ksander, J W StreileinInvestigative Ophthalmology & Visual Science|December 1, 1987
Cell-mediated immune tolerance to HSV-1 antigens associated with reduced susceptibility to HSV-1 corneal lesionsB R Ksander, R L HendricksInvestigative Ophthalmology & Visual Science|February 1, 1989
Analysis of cytotoxic T cell responses to intracameral allogeneic tumorsB R Ksander, J W StreileinJournal of Immunology (Baltimore, Md. : 1950)|October 1, 1990
Failure of infiltrating precursor cytotoxic T cells to acquire direct cytotoxic function in immunologically privileged sitesB R Ksander, J W StreileinJournal of Immunology (Baltimore, Md. : 1950)|July 15, 1989
Recovery of activated cytotoxic T cells from minor H incompatible tumor graft rejection sitesB R Ksander, J W StreileinPageof 7